| Trial ID: | L6360 |
| Source ID: | NCT00570687
|
| Associated Drug: |
Technosphere Insulin
|
| Title: |
A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00570687/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Technosphere Insulin
|
| Outcome Measures: |
Primary: Time to Minimum Endogenous Glucose Production (EGP) - Meal Challenge, Time to minimum EGP post dose, 0-480 minutes|Minimum EGP - Meal Challenge, Minimum calculated EGP per subject as change from baseline, 0-480 minutes|EGP AOC0-480 - Meal Challenge, EGP area over the curve from 0 to 480 minutes postdose, 0-480 minutes |
|
| Sponsor/Collaborators: |
Sponsor: Mannkind Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-09
|
| Completion Date: |
2009-01
|
| Results First Posted: |
2014-10-16
|
| Last Update Posted: |
2014-10-16
|
| Locations: |
Profil Institute for Metabolic Research, Neuss, GER, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00570687
|
